NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 283 filers reported holding NATERA INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,337 | -20.7% | 98,005 | -12.8% | 0.01% | -14.3% |
| Q2 2023 | $5,466 | -44.8% | 112,339 | -37.0% | 0.01% | -46.2% |
| Q1 2023 | $9,905 | +119.1% | 178,406 | +58.6% | 0.01% | +116.7% |
| Q4 2022 | $4,520 | -99.9% | 112,521 | +14.0% | 0.01% | 0.0% |
| Q3 2022 | $4,324,000 | +19.2% | 98,681 | -3.6% | 0.01% | +20.0% |
| Q2 2022 | $3,626,000 | -15.8% | 102,316 | -3.3% | 0.01% | 0.0% |
| Q1 2022 | $4,304,000 | -55.8% | 105,795 | +1.4% | 0.01% | -50.0% |
| Q4 2021 | $9,747,000 | -20.2% | 104,368 | -4.8% | 0.01% | -23.1% |
| Q3 2021 | $12,217,000 | +2.4% | 109,626 | +4.4% | 0.01% | +8.3% |
| Q2 2021 | $11,925,000 | +44.5% | 105,036 | +29.2% | 0.01% | +33.3% |
| Q1 2021 | $8,253,000 | -28.9% | 81,275 | -30.3% | 0.01% | -30.8% |
| Q4 2020 | $11,604,000 | +64.9% | 116,601 | +19.7% | 0.01% | +44.4% |
| Q3 2020 | $7,037,000 | +45.8% | 97,417 | +0.6% | 0.01% | +50.0% |
| Q2 2020 | $4,827,000 | +81.8% | 96,817 | +8.9% | 0.01% | +50.0% |
| Q1 2020 | $2,655,000 | -13.2% | 88,917 | -2.0% | 0.00% | 0.0% |
| Q4 2019 | $3,057,000 | -9.0% | 90,739 | -11.4% | 0.00% | 0.0% |
| Q3 2019 | $3,358,000 | +36.4% | 102,374 | +14.7% | 0.00% | +33.3% |
| Q2 2019 | $2,461,000 | +280.4% | 89,220 | +184.1% | 0.00% | +200.0% |
| Q1 2019 | $647,000 | +47.7% | 31,400 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $438,000 | -51.3% | 31,400 | -16.5% | 0.00% | 0.0% |
| Q3 2018 | $900,000 | +43.1% | 37,600 | +12.6% | 0.00% | 0.0% |
| Q2 2018 | $629,000 | +102.9% | 33,400 | 0.0% | 0.00% | – |
| Q1 2018 | $310,000 | +3.3% | 33,400 | 0.0% | 0.00% | – |
| Q4 2017 | $300,000 | -34.2% | 33,400 | -5.6% | 0.00% | -100.0% |
| Q3 2017 | $456,000 | +18.8% | 35,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $384,000 | +60.7% | 35,400 | +31.1% | 0.00% | – |
| Q1 2017 | $239,000 | -24.4% | 27,001 | +0.0% | 0.00% | – |
| Q4 2016 | $316,000 | +5.3% | 27,000 | 0.0% | 0.00% | – |
| Q3 2016 | $300,000 | -8.0% | 27,000 | 0.0% | 0.00% | – |
| Q2 2016 | $326,000 | +334.7% | 27,000 | +241.8% | 0.00% | – |
| Q1 2016 | $75,000 | -11.8% | 7,900 | 0.0% | 0.00% | – |
| Q4 2015 | $85,000 | – | 7,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |